Notes
Notes - notes.io |
VVC implants in primary TKA are associated with improved functional outcomes and good mid-term survivorship, comparable to lower level of constraint implants. Non-modular stemless seem to be reliable implants at mid-term follow-up. However, given the lack data coming from long-term studies, VVC implants should be used cautiously in primary TKA.
VVC implants in primary TKA are associated with improved functional outcomes and good mid-term survivorship, comparable to lower level of constraint implants. Non-modular stemless seem to be reliable implants at mid-term follow-up. However, given the lack data coming from long-term studies, VVC implants should be used cautiously in primary TKA.
To investigate whether the correction amount by balloon kyphoplasty (BKP) is associated with the incidence of adjacent vertebral fractures (AVF).
Data from 61 patients without and 25 patients with AVF were analyzed. A linear regression model was used between vertebral instability and corrected angle or height to divide patients into the overcorrection and undercorrection groups.
Vertebral fractures overcorrected for instability led to a higher incidence rate of AVF [42.4% and 46.9% with overcorrection vs. 10.7% and 13.3% with undercorrection for angle and height, respectively].
Overcorrection of fractured vertebrae may associate with the increased incidence of AVF.
Overcorrection of fractured vertebrae may associate with the increased incidence of AVF.[This corrects the article DOI 10.1016/j.jor.2020.06.011.][This corrects the article DOI 10.1016/j.jor.2019.08.023.][This corrects the article DOI 10.1016/j.jor.2020.03.020.][This corrects the article DOI 10.1016/j.jor.2019.09.012.][This corrects the article DOI 10.1016/j.jor.2018.08.010.][This corrects the article DOI 10.1016/j.jor.2019.05.012.][This corrects the article DOI 10.1016/j.jor.2019.12.006.][This corrects the article DOI 10.1016/j.jor.2018.08.004.][This corrects the article DOI 10.1016/j.jor.2019.04.012.][This corrects the article DOI 10.1016/j.jor.2018.01.003.][This corrects the article DOI 10.1016/j.jor.2018.01.021.][This corrects the article DOI 10.1016/j.jor.2019.10.019.][This corrects the article DOI 10.1016/j.jor.2019.02.012.][This corrects the article DOI 10.1016/j.jor.2019.08.028.][This corrects the article DOI 10.1016/j.jor.2018.02.004.].[This corrects the article DOI 10.1016/j.jor.2018.08.020.][This corrects the article DOI 10.1016/j.jor.2018.05.041.][This corrects the article DOI 10.1016/j.jor.2020.01.005.][This corrects the article DOI 10.1016/j.jor.2020.02.007.][This corrects the article DOI 10.1016/j.jor.2020.05.024.][This corrects the article DOI 10.1016/j.jor.2019.10.022.][This corrects the article DOI 10.1016/j.jor.2018.08.036.][This corrects the article DOI 10.1016/j.jor.2019.02.021.][This corrects the article DOI 10.1016/j.jor.2020.04.020.][This corrects the article DOI 10.1016/j.jor.2018.01.013.][This corrects the article DOI 10.1016/j.jor.2019.10.016.][This corrects the article DOI 10.1016/j.jor.2018.08.025.][This corrects the article DOI 10.1016/j.jor.2020.04.021.][This corrects the article DOI 10.1016/j.jor.2019.02.026.][This corrects the article DOI 10.1016/j.jor.2018.05.016.][This corrects the article DOI 10.1016/j.jor.2018.12.007.].[This corrects the article DOI 10.1016/j.jor.2019.06.021.][This corrects the article DOI 10.1016/j.jor.2020.03.045.][This corrects the article DOI 10.1016/j.jor.2020.03.039.][This corrects the article DOI 10.1016/j.jor.2020.03.009.][This corrects the article DOI 10.1016/j.jor.2020.03.056.][This corrects the article DOI 10.1016/j.jor.2019.09.006.][This corrects the article DOI 10.1016/j.jor.2018.08.031.][This corrects the article DOI 10.1016/j.jor.2019.02.004.][This corrects the article DOI 10.1016/j.jor.2018.08.018.][This corrects the article DOI 10.1016/j.jor.2020.06.012.][This corrects the article DOI 10.1016/j.jor.2018.03.021.][This corrects the article DOI 10.1016/j.jor.2019.02.003.][This corrects the article DOI 10.1016/j.jor.2018.08.012.][This corrects the article DOI 10.1016/j.jor.2019.06.023.][This corrects the article DOI 10.1016/j.jor.2020.03.034.].Several immunodiagnostic assays have been commercially presented over the last years as easy diagnostic methods for schistosomiasis using serum or urine samples. The performance of immunochromatographic test (ICT) and indirect hemagglutination assay (IHA) was validated in the identification of active schistosomiasis infection. Detection of circulating cathodic antigen (CCA) of the parasite in urine samples and anti-Schistosoma antibodies in serum using ICT (Urine-CCA Cassette test) and IHA respectively. Proved diagnosis of Schistosoma mansoni infection was defined by the sum of positive results from microscopic examination (Gold standard) and Kato-Katz method. Out of 173 (mean age, 45 ± 10 years; 70 from Giza, 103 from different Egyptian governorates), 9 4 adult patients were infected. Urine-CCA cassette test despite showing high specificity (91.14%) it was of low sensitivity (23.40%). PPVs was 75.86% and NPV was 50.00% and diagnostic accuracy of 54.34%. The IHA showed a sensitivity of 57.45% and specificity of 48.10%. PPVs was 56.84% whereas NPVs was 48.72%. As for diagnostic accuracy, it was 53.18%. Itacitinib concentration Urine-CCA Cassette test had lower sensitivity than expected for detection of circulating antigen and the IHA kit is generally more expensive than microscopic examination and Urine-CCA cassette test with low sensitivity and specificity. On the basis of this diagnostic performance none of the two tested immune-assays can be a sole tool in the principal diagnosis of active schistosomiasis infections.Although canids are regarded as major reservoir hosts for Leishmania infantum, feline leishmaniasis are reported sporadically from different endemic foci of Mediterranean visceral leishmaniasis (VL). Despite the risk of parasite transmission between human and other animals, most of the studies are limited to dogs and few studies are focused to investigate Leishmania sp. among other mammals. This project was aimed to detect L. infantum antibodies of cats in two VL endemic regions of Iran by Fucose Mannose Ligand (FML) and soluble L. infantum antigen (SLA) ELISA. Forty nine stray cats of different age and sex, from Fars and Ardabil provinces (two VL endemic loci of Iran) were sampled, then tested for L. infantum by FML and SLA-ELISA. Sixteen percent (8/49) of cat sera were reported positive by FML-ELISA. SLA-ELISA showed 18.3% (9/48) positive cases in cats. Sensitivity of FML-ELISA was calculated 57% and SLA ELISA 25%. Specificity of FML and SLA ELISA were assessed 78% and 68% respectively. Kappa coefficient of agreement between FML and SLA-ELISA was detected on 0.
My Website: https://www.selleckchem.com/products/itacitinib-incb39110.html
|
Notes.io is a web-based application for taking notes. You can take your notes and share with others people. If you like taking long notes, notes.io is designed for you. To date, over 8,000,000,000 notes created and continuing...
With notes.io;
- * You can take a note from anywhere and any device with internet connection.
- * You can share the notes in social platforms (YouTube, Facebook, Twitter, instagram etc.).
- * You can quickly share your contents without website, blog and e-mail.
- * You don't need to create any Account to share a note. As you wish you can use quick, easy and best shortened notes with sms, websites, e-mail, or messaging services (WhatsApp, iMessage, Telegram, Signal).
- * Notes.io has fabulous infrastructure design for a short link and allows you to share the note as an easy and understandable link.
Fast: Notes.io is built for speed and performance. You can take a notes quickly and browse your archive.
Easy: Notes.io doesn’t require installation. Just write and share note!
Short: Notes.io’s url just 8 character. You’ll get shorten link of your note when you want to share. (Ex: notes.io/q )
Free: Notes.io works for 12 years and has been free since the day it was started.
You immediately create your first note and start sharing with the ones you wish. If you want to contact us, you can use the following communication channels;
Email: [email protected]
Twitter: http://twitter.com/notesio
Instagram: http://instagram.com/notes.io
Facebook: http://facebook.com/notesio
Regards;
Notes.io Team